Project Recommendation | ||
Information on the reference formulation | Common name | Carbosulfan Sodium injection |
Trade Name | Adona | |
English Name | Carbosulfan Sodium injection | |
Dosage form | Injection | |
Specification | 25mg/5ml,50mg/10ml | |
Holder | ニプロESファーマ株式会社 | |
Country of marketing | Japan | |
Features | 【Pharmacology and Toxicology】 This product can reduce capillary permeability, enhance the retraction of capillary rupture, increase capillary resistance to injury, and is commonly used for a variety of bleeding caused by increased capillary permeability. | |
Indications | It is used for bleeding disorders of the urinary system, upper gastrointestinal tract, respiratory tract and obstetrics and gynaecology. It is also used for the prevention and treatment of surgical bleeding. | |
Generic drug registration classification | Classified 3 of Chemicals | |
Project advantages |
|